Article Text
Letter
Impact on gonorrhoea case reports through concomitant/dual testing in a chlamydia screening population in Liverpool
Statistics from Altmetric.com
A recent Commentary in this journal1 encourages wider implementation of nucleic-acid amplification tests (NAATs) to detect gonorrhoea (GC). We have used GC NAATs (APTIMA Combo2; Gen-Probe Inc., San Diego, California, USA) since 2003, with high uptake, in a Liverpool chlamydia screening population and with referral of GC-positive patients to our local genitourinary medicine (GUM) clinic for management.2 We have now observed a doubling of female cases of GC and a reversal of the downward trend for male …
Footnotes
-
Competing interests: None declared